InnoMedCatalyst Open Call

Build the Next Generation of European 5P Medicine Innovation Consortia

Are you developing an innovative solution in Predictive, Preventive, Personalised, Participatory and Precision Medicine (5P Medicine)?

The InnoMedCatalyst project invites innovative companies, start-ups, SMEs, research organisations and healthcare innovators to participate in a unique European consortium-building programme designed to accelerate the development of collaborative innovation projects in 5P Medicine.

If you have an innovative technology, expertise or healthcare solution and are looking for complementary partners to bring your innovation to the next level, this Open Call is for you.

Rather than providing direct financial support, InnoMedCatalyst offers a structured pathway to help innovators build strong multidisciplinary consortia, refine their value proposition and prepare competitive project concepts for future European funding opportunities (including the I3 Instrument and Horizon Europe).

Why Participate?

Selected organisations will have the opportunity to:

• Connect with complementary innovators, researchers, healthcare providers and technology developers across Europe.

• Build multidisciplinary consortia capable of addressing real healthcare challenges.

• Receive up to 20 hours of tailored mentoring and coaching from experienced innovation experts.

• Develop a strong European project proposal concept targeting future calls (i.e. I3 and Horizon Europe).

• Increase the visibility of your innovation within the European precision medicine ecosystem.

• Strengthen your commercialisation strategy and expand your international partnership network.

• Position your organisation at the forefront of next-generation 5P Medicine innovation.



What We Are Looking For

We are seeking early-stage collaborative project ideas that address challenges or opportunities in Predictive, Preventive, Personalised, Participatory and Precision Medicine (5P Medicine).

Applicants should already have the foundation of a collaborative consortium and demonstrate a clear ambition to develop a competitive European project concept.

Each application must:

• Be submitted on behalf of a consortium comprising a minimum of two independent partner organizations.

• Clearly describe the innovation challenge or opportunity being addressed.

• Present an innovative technology, solution, service, research result or clinical application within the field of 5P Medicine.

• Identify the complementary expertise and additional partners required to strengthen the consortium and prepare for future European funding opportunities.

The InnoMedCatalyst consortium-building programme will support selected applicants in expanding their partnerships, strengthening their project concept and developing a competitive interregional consortium.



Who Can Apply?

Applications are welcome from consortia consisting of at least two independent organisations from two different regions; one of the organization needs to be established in one of the following InnoMedCatalyst regions:

• Greece

• Romania

• Bulgaria

• Poland

• Belgium

• Italy

• Spain

• Portugal



Eligible organisations include:

• Start-ups/ Spin-offs

• Small and Medium-sized Enterprises (SMEs)

• Biotechnology companies

• MedTech companies

• Digital Health companies

• Research and Technology Organisations (RTOs)

• Universities

• Hospitals and healthcare providers

The programme particularly encourages multidisciplinary partnerships combining research, healthcare, industry and innovation support organisations.

How the Programme Works

The Open Call follows a collaborative innovation pathway designed to transform individual innovations into competitive European project consortia.

Step 1 – Apply

Submit your organisation, technology, expertise or innovation challenge through the Life Science Open Space Platform until August 31^st. Participation is free of charge and does not provide direct funding.

Step 2 – Evaluation

Applications will be assessed based on innovation excellence, relevance to 5P Medicine and their potential to contribute to multidisciplinary European collaborations.

Step 3 – Selection

Up to 15 organisations will be selected to participate in the consortium-building programme.

Step 4 – Matchmaking

Selected participants will take part in targeted matchmaking activities to identify complementary partners from industry, research organisations, healthcare providers and technology developers.

Step 5 – Consortium Building

Participants will work together to define common objectives, develop integrated solutions and establish competitive European consortia.

Step 6 – Expert Mentoring

Each consortium will receive up to 20 hours of dedicated mentoring, including support on:

• consortium development

• value proposition refinement

• business model development

• commercialisation strategy

• technology validation pathways

• proposal development

• identification of suitable European funding opportunities

Step 7 – Proposal Development

Consortia will prepare a mature collaborative proposal outline that can later be expanded into a full application for a suitable European funding call (including Horizon Europe and the I3 Instrument).

Areas of Interest

We welcome innovations across the full spectrum of 5P Medicine, including but not limited to:

• Genomics and biomarker-based diagnostics

• Precision diagnostics

• AI for healthcare

• Digital Health solutions

• Clinical Decision Support Systems

• Personalised therapies

• Medical devices

• Health data platforms

• Data interoperability

• Predictive analytics

• Remote monitoring

• Patient engagement technologies

• Digital therapeutics

• Precision prevention

• Multi-omics technologies

Selection Criteria

Applications will be evaluated based on:

• Innovation excellence and technological maturity.

• Relevance to the objectives of 5P Medicine.

• Potential contribution to multidisciplinary European consortia.

• Commercialisation potential and scalability.

• Commitment to collaboration and participation throughout the programme.

• Potential to develop competitive European project concepts.



Expected Commitment

Selected consortia will be expected to:

• Build upon their existing partnership of at least two organisations and actively engage in expanding their consortium through the InnoMedCatalyst matchmaking activities.

• Participate in consortium-building workshops and networking events.

• Participate in mentoring, proposal development activities and business development activities.

• Support the preparation of at least one collaborative European project proposal.

• Collaborate with complementary partners from across the InnoMedCatalyst regions.

• Contribute to the development of a competitive European project concept targeting future Horizon Europe, I3 or other relevant European funding opportunities.

• Nominate a lead organisation to coordinate communications and represent the consortium throughout the programme.

About InnoMedCatalyst

InnoMedCatalyst is an Interregional Innovation Investments (I3) project that strengthens regional innovation ecosystems in precision and personalised medicine. The project supports start-ups, SMEs, healthcare providers and research organisations in developing investment-ready digital health and precision medicine solutions through collaboration, mentoring and international partnerships.

By connecting innovators across regions, InnoMedCatalyst aims to accelerate the commercialisation of healthcare innovation while creating sustainable European value chains in 5P Medicine.

Apply Now

Submit your application through the Life Science Open Space Platform:

Application Deadline: 31 August 2026

Application Language: English

For further information, please contact:

innomedcatalyst@medicnest.eu